We are at #JPM2025 talking about our unique, milestone-based funding model and the case study of our recent Sprint for Women's Health – a $113M investment. In this article, Dr. Renee Wegrzyn offers insights into how and why a federal funding agency is doing business differently. Not only are we accelerating medical breakthroughs but also fueling economic growth and investment in the health sector through the non-dilutive capital we provide.
Advanced Research Projects Agency for Health (ARPA-H)
Government Administration
Bethesda, MD 23,800 followers
Accelerating better health outcomes for everyone.
About us
The Advanced Research Projects Agency for Health (ARPA-H) is committed to solving the most challenging problems in health by developing research programs dedicated to urgency, excellence and honesty. Part of the U.S. Department of Health and Human Services, ARPA-H aims to accelerate breakthroughs that empower every American to realize their full health potential – turning the seemingly impossible to the possible to the actual. The ARPA model is a continuous cycle of planning, implementing, and evaluating, and we’re looking for the best ideas and the brightest minds to carry out each process. Find more information about the agency and current job opportunities at https://arpa-h.gov
- Website
-
http://arpa-h.gov
External link for Advanced Research Projects Agency for Health (ARPA-H)
- Industry
- Government Administration
- Company size
- 51-200 employees
- Headquarters
- Bethesda, MD
- Type
- Government Agency
- Founded
- 2022
Locations
-
Primary
Get directions
Bethesda, MD 20892, US
Employees at Advanced Research Projects Agency for Health (ARPA-H)
Updates
-
Our project with Sun Vectors Inc. aims to establish a platform for a more precise, scalable, and cost-effective process of gene therapy manufacturing. https://lnkd.in/eSbXXR6m
ARPA-H Project Awardees
arpa-h.gov
-
How are we tackling aging? Our new PROSPR program aims to unlock the early signals in your body that predict age-related health issues before they happen. https://lnkd.in/gf-23pXt
PROSPR
arpa-h.gov
-
Join our Director of Scalable Solutions, Jason Roos, at #PMWC25, February 5-7! Dr. Roos is addressing PGx myths on the “PGx is Hard to Implement” panel. https://lnkd.in/e5QPqBGw
-
-
Advanced Research Projects Agency for Health (ARPA-H) reposted this
Yesterday at #JPM25, Cure CEO Seema Kumar had the exciting privilege of moderating a fascinating panel for the Advanced Research Projects Agency for Health (ARPA-H) titled "Through Non-Dilutive Capital - Women's Health As A Case Study." During the discussion, ARPA-H Director Renee Wegrzyn shared valuable insights on why entrepreneurs should see ARPA-H as a supportive investor rather than just a government agency. She highlighted their Sprint for Women's Health initiative as an excellent example of how the agency's model provides outcome-based contracts, which are more tailored to the specific efforts of companies, unlike traditional grants. ARPA-H Portfolio Lead Jenica Patterson, who oversaw the Sprint for Women's Health, showcased impressive achievements, as within less than a year, they awarded 24 companies over $113 million! #investinwomenshealth Among those participating was awardee Sabrina Johnson, the CEO of Daré Bioscience, Inc., whose clinical-stage biopharmaceutical company is committed to advancing innovative products for women's health. She spoke about how her award is helping bring her innovations to market along with ARPA-H Program Manager Ross Uhrich, who talked about an #osteoarthritis program that he leads, which also disproportionally affects women. We at Cure were honored to be part of this incredible conversation and look forward to seeing what breakthroughs ARPA-H will bring to market not only in women's health but also in all diseases that ail us most. #wewillcure #jpm2025 #womenshealth
-
-
Advanced Research Projects Agency for Health (ARPA-H) reposted this
How can we expedite #MedTech's journey to market? Register now to attend a virtual information session on Friday, January 17 to learn more about our new network survey in support of ARPA-H's effort to accelerate medical device and diagnostic reimbursement! Time will be reserved for Q&A. 🔗 Save your spot: https://bit.ly/4abdBx7 Advanced Research Projects Agency for Health (ARPA-H) #MedTech Arunan Skandarajah, PhD
-
-
COMING UP: PATIO Director Craig Gravitz and Technology Transfer and Transition Division Director Maryam Ziaei-Moayyed are speaking at Grant Engine’s Non-Dilutive Funding Summit! https://lnkd.in/eUNYwhKG
-
-
We’re at #BiotechShowcase in San Francisco! Catch Deputy Director Susan Monarez’s workshop: “Financing Future Innovations: Raising the Money Needed to Get to the Next Inflection Point” today, 1/15 at 10:00-11:00 am PT. https://lnkd.in/ePFTZbmK
-
-
🚨 The INDEX solution summary due date has changed to Jan 28, 2025! https://lnkd.in/e3BZyvN2 Full proposals are due March 27, 2025 at 5:00 PM ET
What if a platform existed to help doctors make faster more accurate diagnoses? INDEX intends to create a high-quality medical imaging platform that does not currently exist to benefit the entire imaging ecosystem. https://lnkd.in/eNgzgBt9
-
-
Our diverse funding mechanisms allow us to address the critical health challenges that traditional research and private industry cannot. Our Open Funding Opportunities page lists the areas in which ARPA-H is currently soliciting research applications. Solicitations are time-limited. Check back regularly for new programs! https://lnkd.in/eid9gWq8
New year, new Celmatix! As of today, we’re officially Celmatix Therapeutics. This is the culmination of six years of evolution that started when we announced our first drug program in 2018. Celmatix was founded in 2009 as the first precision medicine company focused uniquely on women’s health. Over 15 years, and with the hard work and dedication of more than 200 employees over the different stages of our journey, we built a groundbreaking dataset encompassing data from over 200,000 unique individuals, leveraged insights from those data to launch digital health and diagnostic products that impacted the lives of over 100,000 patients, and partnered with leading fertility centers, biopharma companies, and numerous top academic institutions. We wanted to do it all, as there is so much unmet need in women’s health. But in 2018, faced with funding realities that forced us to narrow our focus, we decided to look for the biggest impact we could have on the field in the leanest way. And so we launched our Biosciences program to drive innovation in early drug discovery. Many similar precision medicine companies tried and failed to make the pivot from data company to drug company. Many people believed we would fail as well. But we have succeeded, and our name change celebrates this accomplishment. In 6 short years we have made incredible progress including: two of our PCOS programs were licensed to Bayer; our ovarian aging program received a SPARK award from Advanced Research Projects Agency for Health (ARPA-H); we progressed from the start of our oral FSH program to nominating our first lead candidate in 18 months; and today we are excited to announce the launch of our newest drug program aimed at tackling endometriosis. Licensed from our collaborators at Baylor College of Medicine, this latest addition to our growing pipeline has the potential to be the first true cure for this debilitating disease, with the potential to impact other women’s health conditions like PCOS and ovarian aging in the future as well. Learn more here: https://lnkd.in/dhpznTZm Modern women deserve to have all of their organs (including their ovaries!) function well throughout their lifespans, deserve access to better fertility treatments that are easier on their bodies, and deserve access to disease modifying treatments for diseases that uniquely impact their bodies including endometriosis and PCOS. To everyone who’s supported us, believed in our mission, and shared our vision: thank you. You’ve been a vital part of our journey, and we can’t wait to share what’s ahead. Here’s to staying rooted in purpose while growing into the future!
-